These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 17481662)

  • 1. Botulinum toxin A does not alter capsaicin-induced pain perception in human skin.
    Schulte-Mattler WJ; Opatz O; Blersch W; May A; Bigalke H; Wohlfahrt K
    J Neurol Sci; 2007 Sep; 260(1-2):38-42. PubMed ID: 17481662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain.
    Ranoux D; Attal N; Morain F; Bouhassira D
    Ann Neurol; 2008 Sep; 64(3):274-83. PubMed ID: 18546285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcutaneous Botulinum toxin type A reduces capsaicin-induced trigeminal pain and vasomotor reactions in human skin.
    Gazerani P; Pedersen NS; Staahl C; Drewes AM; Arendt-Nielsen L
    Pain; 2009 Jan; 141(1-2):60-9. PubMed ID: 19004549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum Toxin A reduces neurogenic flare but has almost no effect on pain and hyperalgesia in human skin.
    Krämer HH; Angerer C; Erbguth F; Schmelz M; Birklein F
    J Neurol; 2003 Feb; 250(2):188-93. PubMed ID: 12574949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin type A reduces capsaicin-evoked pain and neurogenic vasodilatation in human skin.
    Tugnoli V; Capone JG; Eleopra R; Quatrale R; Sensi M; Gastaldo E; Tola MR; Geppetti P
    Pain; 2007 Jul; 130(1-2):76-83. PubMed ID: 17194546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An open study of botulinum-A toxin treatment of trigeminal neuralgia.
    Piovesan EJ; Teive HG; Kowacs PA; Della Coletta MV; Werneck LC; Silberstein SD
    Neurology; 2005 Oct; 65(8):1306-8. PubMed ID: 16247065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A lack of antinociceptive or antiinflammatory effect of botulinum toxin A in an inflammatory human pain model.
    Sycha T; Samal D; Chizh B; Lehr S; Gustorff B; Schnider P; Auff E
    Anesth Analg; 2006 Feb; 102(2):509-16. PubMed ID: 16428552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial.
    Yuan RY; Sheu JJ; Yu JM; Chen WT; Tseng IJ; Chang HH; Hu CJ
    Neurology; 2009 Apr; 72(17):1473-8. PubMed ID: 19246421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of adrenosensitivity in capsaicin induced hyperalgesia.
    Schattschneider J; Zum Buttel I; Binder A; Wasner G; Hedderich J; Baron R
    Eur J Pain; 2007 Oct; 11(7):756-63. PubMed ID: 17234439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antinociceptive effect of botulinum toxin type a in rat model of carrageenan and capsaicin induced pain.
    Bach-Rojecky L; Lacković Z
    Croat Med J; 2005 Apr; 46(2):201-8. PubMed ID: 15849840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of venlafaxine on ongoing and experimentally induced pain in neuropathic pain patients: a double blind, placebo controlled study.
    Yucel A; Ozyalcin S; Koknel Talu G; Kiziltan E; Yucel B; Andersen OK; Arendt-Nielsen L; Disci R
    Eur J Pain; 2005 Aug; 9(4):407-16. PubMed ID: 15979021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-dependent effects of smoked cannabis on capsaicin-induced pain and hyperalgesia in healthy volunteers.
    Wallace M; Schulteis G; Atkinson JH; Wolfson T; Lazzaretto D; Bentley H; Gouaux B; Abramson I
    Anesthesiology; 2007 Nov; 107(5):785-96. PubMed ID: 18073554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of capsaicin-sensitive afferents and the Transient Receptor Potential Vanilloid 1 Receptor in xylene-induced nocifensive behaviour and inflammation in the mouse.
    Sándor K; Helyes Z; Elekes K; Szolcsányi J
    Neurosci Lett; 2009 Feb; 451(3):204-7. PubMed ID: 19159661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of analgesia by oral standardized cannabis extract on acute inflammatory pain and hyperalgesia in volunteers.
    Kraft B; Frickey NA; Kaufmann RM; Reif M; Frey R; Gustorff B; Kress HG
    Anesthesiology; 2008 Jul; 109(1):101-10. PubMed ID: 18580179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two types of C nociceptors in human skin and their behavior in areas of capsaicin-induced secondary hyperalgesia.
    Serra J; Campero M; Bostock H; Ochoa J
    J Neurophysiol; 2004 Jun; 91(6):2770-81. PubMed ID: 14762154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of intravenous ketorolac on capsaicin-induced deep tissue hyperalgesia.
    Kumar K; Polston GR; Wallace MS
    Anesth Analg; 2006 Sep; 103(3):696-702. PubMed ID: 16931683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different antinociceptive effects of botulinum toxin type A in inflammatory and peripheral polyneuropathic rat models.
    Favre-Guilmard C; Auguet M; Chabrier PE
    Eur J Pharmacol; 2009 Sep; 617(1-3):48-53. PubMed ID: 19576881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychophysics, flare, and neurosecretory function in human pain models: capsaicin versus electrically evoked pain.
    Geber C; Fondel R; Krämer HH; Rolke R; Treede RD; Sommer C; Birklein F
    J Pain; 2007 Jun; 8(6):503-14. PubMed ID: 17434803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Divergent peripheral effects of pituitary adenylate cyclase-activating polypeptide-38 on nociception in rats and mice.
    Sándor K; Bölcskei K; McDougall JJ; Schuelert N; Reglodi D; Elekes K; Petho G; Pintér E; Szolcsányi J; Helyes Z
    Pain; 2009 Jan; 141(1-2):143-50. PubMed ID: 19091468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analgesic effects of low-dose intravenous orphenadrine in the state of capsaicin hyperalgesia. A randomised, placebo-controlled, double-blind cross-over study using laser somatosensory evoked potentials obtained from capsaicin-irritated skin in healthy volunteers.
    Schaffler K; Reitmeir P
    Arzneimittelforschung; 2004; 54(10):673-9. PubMed ID: 15553107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.